Last reviewed 2026-05-15 · How we verify

LEO 29102 Plus Calcipotriol Cream

LEO Pharma · Phase 2 active Small molecule

LEO 29102 Plus Calcipotriol Cream is a Small molecule drug developed by LEO Pharma. It is currently in Phase 2 development.

At a glance

Generic name	LEO 29102 Plus Calcipotriol Cream
Sponsor	LEO Pharma
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

LEO 29102 Plus Calcipotriol Cream CI brief — competitive landscape report
LEO 29102 Plus Calcipotriol Cream updates RSS · CI watch RSS
LEO Pharma portfolio CI

Frequently asked questions about LEO 29102 Plus Calcipotriol Cream

What is LEO 29102 Plus Calcipotriol Cream?

LEO 29102 Plus Calcipotriol Cream is a Small molecule drug developed by LEO Pharma.

Who makes LEO 29102 Plus Calcipotriol Cream?

LEO 29102 Plus Calcipotriol Cream is developed by LEO Pharma (see full LEO Pharma pipeline at /company/leo-pharma).

What development phase is LEO 29102 Plus Calcipotriol Cream in?

LEO 29102 Plus Calcipotriol Cream is in Phase 2.

Manufacturer: LEO Pharma — full pipeline
Compare: LEO 29102 Plus Calcipotriol Cream vs similar drugs
Pricing: LEO 29102 Plus Calcipotriol Cream cost, discount & access